Skip to Content
4

Corcept Therapeutics

  • Previous Rank-
  • Revenue 3 Yr Annual Growth Rate74%
  • Revenue 3 Yr Growth Rank4
  • EPS 3 Yr Annual Growth Rate295%
  • EPS 3 Yr Growth Rank1
  • Total Return 3 Yr Annual Rate27%
  • Total Return 3 Yr Rank49
Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Joseph Belanoff
Websitehttps://www.corcept.com
Country
U.S.
Headquarters
Menlo Park, Calif.
Ticker
CORT
Revenue and net income for the four quarters ended on or before April 30, 2019. Total return for the period ended June 28, 2019.

Revenue, Net Income

Revenue past four quarters ($M)$258
Net Income past four quarters ($M)$76
Market Value as of June 28, 2019 ($M)$1,281

Growth Rates and Ranks

Revenue 3 Yr Growth Rank4
Revenue 3 Yr Annual Growth Rate74%
EPS 3 Yr Growth Rank1
EPS 3 Yr Annual Growth Rate295%
Total Return 3 Yr Rank49
Total Return 3 Yr Annual Rate27%
Beat S&P 500 3 Yr Return (14.2%)
yes